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本次调查发放 2700 份问卷，回收 2521 份，其中有效 2463 份，有效率为 97.7%。
2463 名调查对象中，年龄在 30~39 岁者占 59.0%，93.6%在婚,文化程度为初中/




为 2.843（1.276,6.332）和 1.765（1.454,2.141）；个人月收入、HPV 疫苗知
晓度及宫颈癌家族史是女性为自己接种 HPV 疫苗意愿的影响因素，OR（95%CI）
值分别为 1.162（1.023,1.320）、2.840（2.241,3.600）和 3.271（1.518,7.049）；





















在 HPV 疫苗的健康信念模式中，益处感知和风险感知对 HPV 疫苗接受度影












力，对 HPV 和宫颈癌的风险感知对 HPV 疫苗和宫颈癌筛查接受度的影响较大。
今后为了推广 HPV 疫苗和普及宫颈癌筛查，应考虑相应的影响因素，结合健康
信念模式，有针对性地开展有效的健康教育和干预措施。 

















This study was aimed to analyze the preventive behavior of cervical cancer, 
which included cervical cancer screening and HPV vaccine, among mothers of 
school-age girls in Xiamen. The knowledge, behavior, attitude, and related health 
belief about the preventive behavior were analyzed. The influence factors of the 
women’s preventive behaviorwere identified. Based on the health belief model 
(HBM), the explanation and prediction of various parts of the model for cervical 
cancer preventive behavior were analyzed. 
Methods: 
The objects of this study were mothers of school-age girls in Xiamen, which 
were selected by a multistage random sampling. The data was collected by a 
self-administrated questionnaire survey. The proportions were used to describe social 
demographic characteristics and knowledge, behavior and attitude of cervical cancer 
prevention. Logistic regression was used to analyze the influence factors of 
knowledge, behavior and attitude of cervical cancer prevention. Structural equation 
model were used to verified the hypothesized model, which was assumpted based on 
the HBM. 
Results: 
2700 questionnaires were issused in this study. A total of 2463 were effective, 
while 2521 questionnaires were reclaimed, valid respondent rate was 97.7%. Among 
2463 subjects, 59.0% aged from 30 to 39 years old, 93.6% was in marriage, 57.5% 
has the education level of middle school/high school/vocational school. 42.5% of 
2463 subjects heard of HPV before, 33.0% accepted to vaccine themselves for HPV, 
58.0% were willing to accept HPV vaccine for their daughters, 40.4% had received 















future. 65.5% of the women, which accepted cervical cancer screening in the future, 
were willing to receive the screening in one year. 
According to the results of influence factors analysis, occupation and education 
level of the women would affect their HPV knowledge, ORs were 2.843 and 1.765. 
Personal monthly income, the knowledge of HPV vaccine and family history of 
cervical cancer would affect women’s acceptability of the HPV vaccine for 
themselves, ORs were 1.162, 2.840 and 3.271 respectively. Marital status, school 
grade of the daughters and the knowledge of HPV vaccine would affect women’s 
acceptability of the HPV vaccine for their daughters, ORs were 1.626, 1.043 and 
2.240 respectively. The residence, education degree and the family history of cervical 
cancer associated with whether the respondents had received cervical cancer 
screening, ORs were 0.646, 1.959 and 3.310 respectively. Marital status, educational 
level and the knowledge of cervical cancer screening would affect women’s 
acceptability of cervical cancer screening, ORswere 2.119, 1.530 and 5.180 
respectively. 
Based on the HBM, the structural equation model shows that benefits 
perception of HPV vaccine and risk perception of HPV infection were the stronger 
influence factors of the HPV vaccine acceptability, while the total effects were 0.241 
and 0.223.The total effect of barriers perception on HPV vaccine acceptability was   
-0.117. The knowledge of HPV has direct effect (0.108) and indirect effect (0.075) on 
HPV vaccine acceptability. In the HBM of cervical cancer screening, barriers 
perception, benefits perception, and the cue of action had direct effect on acceptability 
of cervical cancer screening, and the direct effect were -0.435, 0.251 and 0.203 
respectively.The risk perception had indirect effect (0.312) on acceptability of cervical 
cancer screening through barriers and benefit perception. The knowledge of HPV had 
indirect effect (0.127) on acceptability of cervical cancer screening through barriers 
and benefit perception. 
Conclusion: 
While the knowledge of mothers of school-age girls in Xiamen was relatively 















screening was higher than the national average, and women showed strong 
willingness to accept screening in the future.Women’s knowledge, behavior and 
attitude for cervical cancer prevention were associated with their age, education level, 
family history of cervical cancer and marital status.Each part of the HBM has a 
certain ability to explain and predict cervical cancer prevention.In the future in order 
to promote HPV vaccine and cervical cancer screening, the corresponding influencing 
factors should be considered.Combined with the HBM, effective health education and 
intervention measures would be carried out. 
Key words：HPV Vaccine; Cercival Cancer Screening; Influence Factor Analysis; 
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验证实，在注射预防 HPV6、HPV11、HPV16 及 HPV18 型感染的四价疫苗后 5 
年，疫苗的保护率为 96%[6]，在注射预防 HPV16、18 型感染的二价疫苗后的 9.4 




























世纪 50 年代末开始大规模推广宫颈癌普查工作，WHO 公布的宫颈癌死亡率数
据显示，我国的宫颈癌死亡率由 70 年代的世界高水平（10.7/10 万）降至 90 年





然而，人们对 HPV 及宫颈癌的认知极其有限，这不利于推广 HPV 疫苗和推进宫
颈癌筛查[19-24]。在英国的两项研究中，仅有 30%女性听说过 HPV，而在加拿大的
未成年人中，仅有 13%听说过 HPV[5, 6, 9]。大多调查对象从未听说过 HPV，不了
解其发病、传播及危险因素等信息[25-29]。而部分调查对象虽曾听说过 HPV，知





性愿意了解 HPV 相关知识，例如传播途径、临床症状及预防方式等，有 86%受
调查女性希望能在初次性行为之前了解到相关知识[7]。相对于网络媒体、朋友或
家人，医疗工作者被认为是最好的知识信息来源，也能更好地保证信息的准确性。












































高其接种 HPV 疫苗的意向[51, 52]。有许多接受调查的女性表示如果能清楚知道疫
苗对身体的益处的话，能够帮助降低她们对疫苗的恐惧和排斥[25]。（3）行为障
碍感知：指对健康行为过程中可能产生障碍的预估。考虑到 HPV 疫苗的价格，
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